|
|
Article: 'The Drug Target Atlas of Apoptopic Drugs in Oncology' Reports on 90 Unique Drug Target Combinations.
- Article from:
- Business Wire
- Article date:
- February 13, 2008
CopyrightCOPYRIGHT 2008 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c82747) has announced the addition of "The Drug Target Atlas of Apoptopic Drugs in Oncology" to their offering.
The ultimate goal of cancer research is to learn how to make cancer cells selectively die. Apoptosis is the type of death about whose genetically controlled pathways we know the most.
Apoptotic cell death can be triggered by many different cellular stimuli, resulting in activation of apoptotic signalling pathways including extrinsic, intrinsic, and mitochondrial pathways. The plethora of new potential therapeutic drugs has made selection and validation of novel ...